0001179110-21-004092.txt : 20210402
0001179110-21-004092.hdr.sgml : 20210402
20210402150350
ACCESSION NUMBER: 0001179110-21-004092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TULLMAN GLEN
CENTRAL INDEX KEY: 0001213349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 21801731
MAIL ADDRESS:
STREET 1: C/O LIVONGO HEALTH, INC.
STREET 2: 150 WEST EVELYN AVENUE, SUITE 150
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2021-04-01
0
0001477449
Teladoc Health, Inc.
TDOC
0001213349
TULLMAN GLEN
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
0
0
0
Common Stock
2021-04-01
4
M
0
329863
5.26
A
605656
D
Common Stock
2021-04-01
4
S
0
60148
182.7810
D
545508
D
Common Stock
2021-04-01
4
S
0
45089
183.7838
D
500419
D
Common Stock
2021-04-01
4
S
0
44825
184.6821
D
455594
D
Common Stock
2021-04-01
4
S
0
24759
185.7962
D
430835
D
Common Stock
2021-04-01
4
S
0
38977
186.9246
D
391858
D
Common Stock
2021-04-01
4
S
0
98588
187.8532
D
293270
D
Common Stock
2021-04-01
4
S
0
17477
188.4458
D
275793
D
Common Stock
21233
I
See footnote
Common Stock
1812
I
See footnote
Stock Option (right to buy)
5.26
2021-04-01
4
M
0
329863
0
D
2021-04-30
Common Stock
329863
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
Represents the weighted average price of transactions ranging from $182.29 to $183.28. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 8 to this Form 4.
Represents the weighted average price of transactions ranging from $183.29 to $184.28.
Represents the weighted average price of transactions ranging from $184.29 to $185.28.
Represents the weighted average price of transactions ranging from $185.30 to $186.28.
Represents the weighted average price of transactions ranging from $186.30 to $187.29.
Represents the weighted average price of transactions ranging from $187.30 to $188.29.
Represents the weighted average price of transactions ranging from $188.295 to $189.00.
The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, LLC, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The option vested in full on October 30, 2020.
/s/ Adam C. Vandervoort, attorney-in-fact
2021-04-02